Contract 89303022AMA000038
Allianz Research Institute Inc. · Department Of Energy · March 29, 2022
Allianz Research Institute Inc. was awarded a federal contract by Department Of Energy on March 29, 2022 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 25, 2025. If all options are exercised, the contract could reach $250,000.
Contract details
- PIID
- 89303022AMA000038
- Award type
- —
- Pricing
- Firm Fixed Price
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- First action
- March 29, 2022
- Latest action
- June 25, 2025
Description
THE DEPARTMENT OF ENERGY (DOE), OFFICE OF HEADQUARTERS PROCUREMENT SERVICES IS ESTABLISHING MULTIPLE FIRM FIXED PRICE (FFP) BPAS TO PROVIDE COVID-19 TEST KITS AS NEEDED TO MULTIPLE FIELD SITES THROUGH
Modification timeline
-
June 25, 2025Mod P00001THE DEPARTMENT OF ENERGY (DOE), OFFICE OF HEADQUARTERS PROCUREMENT SERVICES IS ESTABLISHING MULTIPLE FIRM FIXED PRICE (FFP) BPAS TO PROVIDE COVID-19 TEST KITS A$0
-
March 29, 2022Base awardTHE DEPARTMENT OF ENERGY (DOE), OFFICE OF HEADQUARTERS PROCUREMENT SERVICES IS ESTABLISHING MULTIPLE FIRM FIXED PRICE (FFP) BPAS TO PROVIDE COVID-19 TEST KITS A$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Uweport Llc | Department Of Energy | July 24, 2025 | $0 |
| Mad Property & Tech Llc | Department Of Energy | June 25, 2025 | $0 |
| Qyk Brands Llc | Department Of Energy | June 25, 2025 | $0 |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 89303022AMA000038?
Contract 89303022AMA000038 is a federal contract awarded to Allianz Research Institute Inc. by Department Of Energy on March 29, 2022 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 89303022AMA000038?
Allianz Research Institute Inc. won contract 89303022AMA000038 from Department Of Energy.
How much is contract 89303022AMA000038 worth?
Contract 89303022AMA000038 has obligated $0 to date but carries a potential ceiling of $250,000 if fully funded and all options are exercised.